Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPCH vs MRNA✓SelectedUSD · MRNASPCH vs MRNA performance historyLatest closeAs of-15.39%11/20
Stock and ETF performance explorer

SPCH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-68.7%
MRNA return
+279.6%
Excess return
-348.3%
Maximum drawdown
-75.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-15.4%-2.2%-13.2%-15.3%
7D-16.6%-12.7%-3.9%-16.2%
30D-39.7%-20.7%-19.0%-39.1%
3M-20.2%+46.3%-66.5%-20.5%
All-68.7%+279.6%-348.3%-73.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · Available span rolling